Kenneth D. Tew - Concepedia

Author

Kenneth D. Tew

Fox Chase Cancer Center ORCID

Also Known As

K D Tew, K Tew, K. D. Tew, K.D Tew, K.D. Tew, KENNETH D. TEW, Kenneth D Tew, Kenneth D. Tew, Kenneth Tew, KennethD. Tew

356

Publications

24.8K

Citations

H-Index

141

Concepts

All Affiliations

Fox Chase Cancer Center Medical University of South Carolina

About

Kenneth D. Tew is an author at Fox Chase Cancer Center specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	81	5.3K
2	Natural Sciences	24	32	1.7K
3	Health Sciences	5	5	306
4	Engineering	3	3	139
5	Social Sciences	3	3	120

Kenneth D. Tew

140

Publications

10.1K

Citations

H-Index

Page 1

	Year	Citations
Glutathione-Associated Enzymes In Anticancer Drug Resistance Kenneth D. Tew Cancer Research Chemoprevention StrategyBiochemistryOncogenic AgentMedicineGlutathione Pathways	2016	858
Molecular Modes of Action of Artesunate in Tumor Cell Lines Thomas Efferth, Axel Sauerbrey, Armin Olbrich, Molecular Pharmacology	2003	428
Cellular Thiols and Reactive Oxygen Species in Drug-Induced Apoptosis Warren Davis, Ze’ev A. Ronai, Kenneth D. Tew Journal of Pharmacology and Experimental Therapeutics	2001	351
Glutathione S-transferase P1–1 (GSTP1–1) Inhibits c-Jun N-terminal Kinase (JNK1) Signaling through Interaction with the C Terminus Tieli Wang, Pinar Arifoglu, Ze’ev A. Ronai, Journal of Biological Chemistry	2001	311
Novel Role for Glutathione S-Transferase π Danyelle M. Townsend, Yefim Manevich, Lin He, Journal of Biological Chemistry	2008	294
Glutathione S-Transferase p Elicits Protection against H2O2-induced Cell Death via Coordinated Regulation of Stress Kinases Zhimin Yin, Vladimir N. Ivanov, Hasem Habelhah, PubMed	2000	267
Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. G. R. Hudes, Richard E. Greenberg, Robert L. Krigel, Journal of Clinical Oncology	1992	256
Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines. Kei Nakagawa, Nagahiro Saijo, Shigeki Tsuchida, Journal of Biological Chemistry ImmunologyPathologyCellular PharmacologyPharmacotherapyImmunotherapy	1990	197
A Novel Role for Human Sulfiredoxin in the Reversal of Glutathionylation Victoria J. Findlay, Danyelle M. Townsend, Taylor E. Morris, Cancer Research	2006	192
Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Kenneth D. Tew, Anne Monks, Linda R. Barone, Molecular Pharmacology	1996	177

Page 1